ArticleAnnals of surgical oncology2025
National Trends and Impact of Preoperative CT-Angiography on Autologous Breast Reconstruction.
Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrior studies investigating the impact of preoperative computed tomography (CT)-angiography (pCTA) on outcomes for autologous breast reconstruction (ABR) have had conflicting results, in part because they have been largely limited to single-center studies with limited sample size. Larger, nationwide studies are needed to better understand the trends and outcomes associated with pCTA for ABR. PATIENTS AND
methodsUsing ICD-9/CPT codes, we identified patients who underwent ABR with and without pCTA between 2010 and 2022 in a national administrative claims database; 90-day complication rates, costs, length of hospital stay (LOS), and trends in usage of pCTA were evaluated.
resultsOf 6372 ABR patients, 4059 (63.7%) did not undergo pCTA and 2313 (36.3%) underwent pCTA. ABR patients with (versus without) pCTA generally had delayed (versus immediate) ABR and a higher body mass index (BMI) and other comorbidities. Annual rate of pCTAs increased from 30% in 2010 to 43% in 2022. No difference in 90-day outcomes, hospital costs, or LOS was observed in patients undergoing ABR with or without pCTA in multivariable regression analysis.
conclusionsThe use of pCTA for ABR has been gradually rising nationwide and is preferentially used in ABR patients with a generally higher burden of comorbidities. However, despite this growing trend, there appears to be no difference in 90-day outcomes, hospital costs, or LOS between patients undergoing ABR with or without pCTA. Use of pCTA should be carefully considered to avoid unnecessary expense and risks for ABR patients. Additional studies are needed to establish standardized protocols to determine which ABR patients would most benefit from pCTA use.
Indexed as
Identifiers
40388031What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.